Health Secretary Robert F. Kennedy Jr. rejected suggestions that the Trump administration should merely suggest a possible link between Tylenol and autism, and instead launched a full-blown assault on the drug’s active ingredient, acetaminophen, according to a report.

Health officials tapped to lead agencies under Kennedy agreed there should be some warning about the painkiller, but wanted to focus on touting leucovorin, a form of vitamin B9, as a potential therapy for autism, according to The Wall Street Journal.

However, after Kennedy met with Kirk Perry, the interim CEO of Tylenol-maker Kenvue, earlier this month, RFK Jr. decided that warning pregnant women about the potential risk of taking acetaminophen should take full priority.

This decision led to the extraordinary press confere

See Full Page